Executive Team

Founder of Know Labs, Ron has 30 years of board, business development, financial, and executive leadership experience from industries including therapeutics, mobile technologies, and software. Previously, Chairman and CEO of eCharge Corporation, Chairman and Co-founder of Blue Frog Mobile, Chairman and CEO of GlobalTel Resources, and Chairman and CEO of Egghead Software.

Former Chief Medical Leader, Diabetes and Endocrinology at Eli Lilly, Chief of Medicine at the US Army Medical Research Institute for Infectious Diseases, Director at Generex, and Medical Director at Catapult Health.

Pete has over 34 years of corporate finance and equity capital markets experience, and over 20 years of specialization in strategic IP analysis, development, and monetization. He most recently served as Senior MD and Head of IP Banking at Boustead Securities. Pete has also held leadership roles at ipCreate, ipCapital Venture Group, MDB Capital Group, The Analytiq Group / RDEX Research, Roth Capital Partners, and Lehman Brothers. He was on the founding team and Head of Equity Capital Markets at E*Offering, the investment bank of E*Trade.

Leo has nearly 25 years of experience across multiple disciplines and has served as a strategy consultant, general manager, and P&L leader at several companies, including Rivian Automotive during its early prototype and commercialization stages, as well as Jarden Corporation and Vista Outdoor, Inc, two multi-billion consumer goods public companies. Skilled in the fields of corporate strategy, business development, operations, and marketing.

Dominic Klyve, Ph.D., a long-time consultant and previous employee of the Company, joins as Chief Science Officer. Dr. Klyve previously served as lead data scientist at Know Labs. As Chief Science Officer, he will be responsible for leading the research and development team in its efforts to build the first non-invasive glucose monitor. Klyve has been an author on several studies published by Know Labs, including its most recent peer-reviewed study published in IEEE Sensors Journal detailing historical developments and limitations with RF-based sensing technologies, and the distinctiveness of Know Labs’ sensor architecture and trade-secret prediction machine learning algorithm. Klyve is the author of more than 80 peer-reviewed publications in several fields of science and mathematics and has served as Principal Investigator on grants from the National Science Foundation (among others) worth over $1.5 million. He holds a professorship at Central Washington University, where he is currently on sabbatical, and is a former Editor of the College Mathematics Journal.

John Cronin joins the day-to-day team as Interim Chief Technology Officer. Previously, Cronin was elected as a member of the Company’s Board of Directors. He has been a strategic advisor and consultant to Know Labs, supporting the Company’s expanding patent portfolio and securing its global leadership as the top patent holder in the non-invasive blood glucose monitoring category. Cronin will oversee the Company’s product development and technology strategy and help the Know Labs team develop test protocols to address research and development questions. In addition, Cronin spearheads the Know Labs “skunkworks” activities which explores new applications for the Company’s platform technology, an example of which is the recently announced automobile steering wheel application of our sensor platform. Cronin is the founder and CEO of ipCapital Group, Inc., a leading global advisory company on intellectual property strategy and monetization. Cronin began his career at IBM where he was the sole inventor of breakthrough chip design technology and later, he became IBM’s top inventor. He went on to create the IBM Patent Factory, growing IBM’s patent portfolio from ninth to first in the world catapulting IBM’s IP licensing from $30 million to over $2 billion a year. Today, Mr. Cronin has approximately 1800 patents and applications worldwide.